Pain Easing For Aussie Phosphagenics After Phase I Results Follow CEO Fraud Allegations
This article was originally published in PharmAsia News
Executive Summary
After fraud allegations involving its chief executive, Phosphagenics reports promising Phase I results for its transdermal oxymorphone patch.